melatonin has been researched along with Central Retinal Edema, Cystoid in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of melatonin for the treatment of chronic central serous chorioretinopathy (CSCR)." | 9.20 | Therapeutic benefit of melatonin in refractory central serous chorioretinopathy. ( Gramajo, AL; Juárez, CP; Luna, JD; Marquez, GE; Rosenstein, RE; Torres, VE, 2015) |
| "Melatonin acts as an antioxidant and regulator of mitochondrial bioenergetics and has a protective effect against ocular diseases." | 5.62 | Melatonin prevents blood-retinal barrier breakdown and mitochondrial dysfunction in high glucose and hypoxia-induced in vitro diabetic macular edema model. ( Chasan, T; Doğanlar, O; Doğanlar, ZB; Güçlü, H; Kurtdere, K; Turgut, E, 2021) |
| "To evaluate the efficacy and safety of melatonin for the treatment of chronic central serous chorioretinopathy (CSCR)." | 5.20 | Therapeutic benefit of melatonin in refractory central serous chorioretinopathy. ( Gramajo, AL; Juárez, CP; Luna, JD; Marquez, GE; Rosenstein, RE; Torres, VE, 2015) |
| "Melatonin acts as an antioxidant and regulator of mitochondrial bioenergetics and has a protective effect against ocular diseases." | 1.62 | Melatonin prevents blood-retinal barrier breakdown and mitochondrial dysfunction in high glucose and hypoxia-induced in vitro diabetic macular edema model. ( Chasan, T; Doğanlar, O; Doğanlar, ZB; Güçlü, H; Kurtdere, K; Turgut, E, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doğanlar, ZB | 1 |
| Doğanlar, O | 1 |
| Kurtdere, K | 1 |
| Güçlü, H | 1 |
| Chasan, T | 1 |
| Turgut, E | 1 |
| Gramajo, AL | 1 |
| Marquez, GE | 1 |
| Torres, VE | 1 |
| Juárez, CP | 1 |
| Rosenstein, RE | 1 |
| Luna, JD | 1 |
1 trial available for melatonin and Central Retinal Edema, Cystoid
| Article | Year |
|---|---|
Therapeutic benefit of melatonin in refractory central serous chorioretinopathy.
Topics: Administration, Oral; Adult; Aged; Antioxidants; Central Serous Chorioretinopathy; Female; Fluoresce | 2015 |
1 other study available for melatonin and Central Retinal Edema, Cystoid
| Article | Year |
|---|---|
Melatonin prevents blood-retinal barrier breakdown and mitochondrial dysfunction in high glucose and hypoxia-induced in vitro diabetic macular edema model.
Topics: Apoptosis; Aryl Hydrocarbon Receptor Nuclear Translocator; Blood-Retinal Barrier; Cell Hypoxia; Cell | 2021 |